A Study to Evaluate Effect of AZD6234 as an Adjunct to Incretin-based Therapies in Adult Participants With Obesity or Overweight With Weight-related Comorbidity With or Without Type 2 Diabetes Mellitus
Clinical trial NCT07776509 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07776509
- Sponsor
- AstraZeneca
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2026-08-21
- Primary completion
- 2028-08-09
- Enrollment
- 500
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.